Genomics & Biotechnology ETF (GNOM) is a Global X ETF with a 0.50% expense ratio, 51 holdings and $104MM in net assets. Largest sector: Healthcare (100%).
Fee
0.50%
expense ratio
Net assets
$104MM
Launched
Apr 5, 2019
Holdings
51
as of Oct 23, 2026
Top 10 weight
54.3%
largest ten holdings
Largest sector
Healthcare
99.7%
Yield
TTM 0.17%
as of Oct 12, 2026
Benchmark
Solactive Genomics Index
GNOM's holdings are as of Oct 23, 2026.
Healthcare
99.7%
Technology
0.3%
1
MRNA
MODERNA
10.47%
2
TWST
TWIST BIOSCIENCE
6.25%
3
TXG
10X GENOMICS INC-CLASS A
6.15%
4
ILMN
ILLUMINA
6.01%
5
NTRA
Natera
5.66%
6
GH
Guardant Health
5.50%
7
QIA
QIAGEN NV
3.67%
8
TECH
BIO TECHNE
3.61%
9
VRTX
VERTEX PHARMACEUTICALS
3.48%
10
1548
GENSCRIPT BIOTECH
3.48%
11
BMRN
BioMarin Pharmaceutical
3.01%
12
CAI
Caris Life Sciences
2.93%
13
VCYT
VERACYTE
2.84%
14
CRSP
CRISPR THERAPEUTICS AG
2.55%
15
CDNA
CareDx
2.41%
16
BNTX
Biontech Se
2.36%
17
ARWR
Arrowhead Pharmaceuticals
2.28%
18
PRAX
Praxis Precision Medicines
2.18%
19
LEGN
LEGEND BIOTECH ADR REP
2.16%
20
LLY
ELI LILLY
2.00%
21
GILD
GILEAD SCIENCES
1.71%
22
BEAM
BEAM THERAPEUTICS
1.70%
23
BLLN
Billiontoone
1.62%
24
SRPT
Sarepta Therapeutics
1.34%
25
AZN
ASTRAZENECA
1.27%
1–25 of 51
Funds listed by how much of their largest holdings they share with GNOM — not a ranking.
Data from Global X; prices and returns from market data. Page updated October 29, 2026. Holdings and figures change over time. For information only — not investment advice.